Page 76 - Virtual Vascular Vol 8
P. 76

Examples of cell salvage system (“cell saver”)                                                                                                           A Ashorth, et al. Cell salvage as part of a blood conservation

                                                                                                                                                                                 strategy in anaesthesia. BJA. 2010;105:401-416




          Problems with massive allogenic blood transfusion:
          •    Risk of transfusion reactions and transfusion related infection
          •    Acidosis                                                                                                     How the blood is “saved”:

          •    Hypothermia
          •    Coagulopathy                                                                                                 1.    Blood is suctioned into the system from clean surgical field (to
          •    Electrolytes disturbance                                                                                           minimise contamination) with a large diameter catheter tip

          •    Citrate toxicity                                                                                                   (to prevent haemolysis)
          •    Transfusion related acute lung injury

                                                                                                                            2.    Blood passes through a filter to remove debris
          Benefits of using cell savers:
          •    Reduce risks of transfusion                                                                                  3.    Washing with isotonic solution (e.g. saline) and centrifugation
          •    Reduce reliance on blood donation                                                                                  to remove components other than red blood cells

          •    Suitable in patients with multiple antibodies in blood or with rare blood types
          •    May be applicable to patients who refuses allogenic blood transfusion (e.g.                                  4.    End product ready for autotransfusion
               Jehovah’s witness)                                                                                                   •     Yield of 50%-95.8% of all RBC retrieved from the system



        76                                                                                                                                                                                                                            77
   71   72   73   74   75   76   77   78   79   80   81